Interacting Drugs |
Zidovudine vs DOXOrubicin (Liposomal) |
Security Level |
 |
Mechanism |
DOXOrubicin (Liposomal): May enhance the adverse/toxic effect of Zidovudine. DOXOrubicin (Liposomal) may diminish the therapeutic effect of Zidovudine. |
Management |
Consider therapy modification |
Zidovudine vs DOXOrubicin (Liposomal)
Post Review about Zidovudine vs DOXOrubicin (Liposomal) Click here to cancel reply.
Other Interactions of Zidovudine
Other Interactions of DOXOrubicin (Liposomal)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.